Fifth Circuit weighs Louisiana bid to restrict telehealth access to mifepristone
The Fifth Circuit heard Louisiana’s challenge to telehealth mifepristone access, but FDA rules remain in place while the appeal proceeds.
The Fifth Circuit heard Louisiana’s challenge to telehealth mifepristone access, but FDA rules remain in place while the appeal proceeds.